2m 2m 2m 2m 2m 2m 2m
MAXCYTE (MXCT)
NASDAQ
$1.11-$0.02 (-2.21%)
Price as of Nov 11, 2026 7:56 PM EST- $116.6MMarket Cap
- -27.10%1-Year Change
- Medical DevicesIndustry
MAXCYTE (MXCT)
$1.11-$0.02 (-2.21%)
MXCT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.13 | ||
Change | -$0.17 (-13.08%) | ||
Open | $1.40 | ||
High | $1.42 | ||
Low | $1.08 | ||
Previous Close | $1.30 | ||
Volume | 4,483,050 | ||
30-Day Average Volume | 1,865,524 | ||
1-Week Change | -22.60% | ||
1-Month Change | 11.88% | ||
1-Year Change | -27.10% | ||
3-Year Change | -65.65% | ||
5-Year Change | -89.44% | ||
Fundamentals | |||
Shares Outstanding | 103.2M | ||
Total Assets | $182.5M | ||
Market Cap | $116.6M | ||
Enterprise Value | $105.3M | ||
Period: QTR TTM FY | |||
Revenue | $10.2M | ||
Net Income | -$4.8M | ||
Free Cash Flow | -$5.6M | ||
EBIT | -$4.8M | ||
EBITDA | -$3.9M | ||
Net Working Capital | $108.8M | ||
EPS | -$0.05 | ||
Enterprise Value/EBITDA | -27 | ||
Enterprise Value/Revenue | 10 | ||
P/B | 1 | ||
P/E | -23 | ||
PEG | -1 | ||
Price/Free Cash Flow | -21 | ||
Price/Operating Cash Flow | -21 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue